Independent EA Review: Backtest Any Trading Robot Before You Buy

Get an independent EA review with out-of-sample testing, realistic costs, and Monte Carlo drawdown. Plain-English verdict in 3 days. No lock-in.

A trader in Dubai wires $497 for an EA marketed with a five-year backtest showing 40% annual returns and a smooth equity curve. Three weeks later, on a live MT5 account with real spreads and slippage, the same EA is down 12%. The seller's backtest was curve-fitted to one historical window with zero commission and instant fills. Nobody ran an independent EA review before the money moved.

This is the most common way retail traders, prop-challenge takers, and small funds lose capital on third-party systems: they trust a vendor's own numbers. A vendor backtest is marketing material, not due diligence. It rarely includes out-of-sample data, walk-forward validation, realistic spread and slippage assumptions, or a Monte Carlo view of worst-case drawdown sequences.

This guide covers what a proper independent EA review actually checks, how the process runs from kickoff to verdict, what it costs, and what you need to have ready before requesting one. The offer is here: Strategy Backtest & Validation Report.

What Strategy Backtest & Validation Report actually does

It is an independent, quant-style check of a trading strategy, indicator, or EA — run in your own platform (TradingView, MT5 Strategy Tester, or Python) using your own data feed and your own account currency. The point is to answer one question before capital is at risk: does this system's edge survive contact with data it was not built on, and with costs that resemble live trading?

The review separates in-sample performance (how the strategy looks on the data it was tuned against) from out-of-sample and walk-forward performance (how it holds up on data it never saw). It applies realistic spread, commission, and slippage assumptions rather than the zero-cost defaults many backtesting platforms ship with. It then runs a Monte Carlo simulation on the trade sequence to show a range of plausible drawdowns and a rough risk-of-ruin figure, rather than the single lucky equity curve a vendor typically shows. The output is a written verdict in plain English — not a stack of raw metrics you have to interpret yourself.

How it works, step by step

Kickoff call or form — you send the EA file, indicator script, or strategy rules, plus the instrument, timeframe, and account type you intend to trade.
Platform match — the review is run in whichever platform the strategy actually runs on: MT5 Strategy Tester for EAs, TradingView Pine for indicators, or Python (backtrader/vectorbt-style) for anything custom.
Data and cost assumptions set — historical data window is split into in-sample and out-of-sample segments; spread, commission, and slippage are set to match your broker's typical live conditions, not the platform default.
Walk-forward run — the strategy is re-optimized on rolling windows and tested forward, to check whether performance is a genuine edge or a fit to one historical stretch.
Monte Carlo drawdown pass — trade sequence is reshuffled thousands of times to produce a distribution of drawdown outcomes and an estimated risk-of-ruin at your stated position sizing.
Verdict drafted — findings are written up in plain English with parameter-sensitivity notes (which inputs the results are fragile to).
Delivery and Q&A — report is sent, with a short window for follow-up questions on any assumption before you decide.

Customer: Here's the EA file and the vendor's brochure. It shows 38% annual return over 5 years, no losing month. Agent: Noted. We'll run this in MT5 Strategy Tester with your broker's typical spread and a 30% out-of-sample holdout the vendor didn't include. Customer: What if it fails on the holdout? Agent: Then the verdict will say so plainly, with the walk-forward numbers and where the edge breaks down — so you're not guessing.

Before and after

Situation	Before	After
Evaluating a purchased EA	Trusting the vendor's own backtest and marketing screenshots	Independent out-of-sample and walk-forward numbers on your own broker's cost assumptions
Estimating worst-case risk	Single equity curve, no sense of drawdown range	Monte Carlo distribution with a risk-of-ruin estimate at your position size
Judging a signal service	Subscribing on trust, cancelling after losses	Verdict before subscribing, based on the signal's actual trade history
Passing a prop firm challenge	Running the strategy live and hoping it holds	Stress-tested beforehand against the firm's drawdown rules
Comparing parameter settings	Guessing which settings are "safe"	Parameter-sensitivity notes showing which inputs the result depends on
Re-checking a strategy after months live	No process, decision made on gut feel	Optional monthly re-validation on new data via the care plan

What it costs and what is included

Item	Price	Notes
Setup: full backtest & validation report	$299 one-time	Includes out-of-sample, walk-forward, Monte Carlo drawdown, written verdict
Care plan	$49/month	Monthly re-validation on new market data; optional, cancel anytime
Platform, data, or telephony costs	Billed direct to client	e.g., paid data feeds, TradingView/MT5 subscription tiers, broker fees
Contract terms	No lock-in	Cancel the care plan anytime; the one-time report has no recurring obligation

The setup fee is typically smaller than a single losing month on an unvetted EA, and far smaller than an EA purchase price plus the capital risked trading it live. The care plan exists because market regimes shift — a strategy validated in Q1 conditions can behave differently by Q3, so re-validation is priced to be cheaper than re-running the full report from scratch.

Delivery timeline

Day 0 — Kickoff

Strategy files, instrument, timeframe, and broker cost profile are collected; platform and data window are confirmed.

Day 1-2 — Build

Out-of-sample split, walk-forward runs, and Monte Carlo simulation are executed; findings are drafted.

Day 3 — Go-live

Written verdict delivered with parameter-sensitivity notes; short Q&A window on assumptions.

What you need to have ready

The EA file, indicator script, or a written strategy rule set (entry, exit, sizing logic)
Target instrument(s) and timeframe(s)
Broker name and account type, or typical spread/commission figures if known
Historical data source, if you have a preferred one (otherwise a standard feed is used)
Any prop-firm or platform rules the strategy must respect (max drawdown, daily loss limits)
Confirmation of who owns the strategy IP, if it was purchased or licensed from a third party

Doing it yourself vs done-for-you

Factor	DIY	Done-for-you
Tools needed	MT5 Strategy Tester, TradingView Pine, or Python + backtesting library	Same tools, run by someone independent of the strategy's outcome
Time cost	Days to weeks learning walk-forward and Monte Carlo methodology correctly	3 days, no learning curve required
Common failure point	Testing only in-sample, using default zero-cost assumptions, unconscious bias toward a strategy you already paid for	Independent party with no stake in the strategy passing
Output	Raw metrics you must interpret yourself	Plain-English verdict with sensitivity notes
Ongoing check-ins	Manual, easy to skip	Optional monthly re-validation via care plan

DIY is entirely viable if you already know walk-forward methodology and can be honest about a strategy you've paid for — the independence is the harder part to self-supply, not the technical skill.

Compliance and risk notes

This report is an analytical review, not investment advice or a guarantee of future performance — treat the verdict as one input to your decision, not the whole decision.
Historical backtest results, even out-of-sample, do not guarantee live results; market conditions change.
If the strategy or EA is licensed from a third party, confirm you have rights to share the code or logic for review purposes.
Broker-specific execution (requotes, partial fills) can differ from simulated slippage assumptions; live results should still be monitored.
If the strategy will run under a prop firm's rules, confirm those rules independently — this review tests against stated parameters, not a specific firm's live enforcement.
Data residency and storage of any proprietary strategy code is limited to what's needed to complete the review; ask about deletion after delivery if that matters to you.

Mistakes buyers make

Trusting the vendor's own backtest — always request or commission an out-of-sample test the vendor didn't run themselves.
Ignoring costs in simulation — a backtest with zero spread and instant fills flatters almost any strategy; insist on realistic cost assumptions.
Judging by one equity curve — a single curve hides the range of possible outcomes; ask for a Monte Carlo drawdown view.
Over-optimizing parameters — a strategy tuned to perform perfectly on past data is often fragile; parameter-sensitivity notes reveal this.
Skipping re-validation — a strategy validated once and never rechecked can quietly stop working as conditions shift.

FAQ

What platforms can this review run on?

TradingView (Pine Script strategies), MT5 Strategy Tester (EAs), or Python-based backtesting for custom or proprietary logic. The platform is matched to whatever the strategy actually runs on.

Do I need to share my source code?

For EAs and indicators, yes — the compiled or script file is needed to run it faithfully. If the code is proprietary and you're not comfortable sharing it, a compiled binary can sometimes be tested instead, though transparency is more limited.

What if the strategy fails the review?

The verdict will say so plainly, along with where it breaks down (which parameters, which market regime, which cost assumption). That's the outcome the review exists to catch before capital is at risk.

Can this validate a signal service I'm subscribing to?

Yes, if the signal service's historical trade log or entry/exit rules can be obtained. The review works the same way: out-of-sample check, realistic costs, drawdown simulation.

How is this different from the backtest report my EA vendor gave me?

A vendor's backtest is typically in-sample only, with default cost assumptions, and no independent party checking it. This review adds an out-of-sample holdout, walk-forward testing, realistic costs, and an independent verdict with no stake in the strategy's success.

What does the monthly care plan actually re-check?

It re-runs validation on new market data since the last review, flagging if the strategy's edge is degrading as conditions change — useful for strategies you're actively trading rather than a one-time purchase decision.

Next step

Email support@bharataisaathi.com or message via WhatsApp with your strategy file or rules, target instrument, and broker details. Review the full scope on the offer page or see our process on how we work. Delivery is live within 3 days of kickoff.